— Reaffirms outlook for 2021 —
— Extends $250 million share repurchase program through January 31, 2022 —
London, UK — October 28, 2021 – Clarivate Plc (NYSE: CLVT) (the “Company” or “Clarivate”), a global leader in providing trusted information and insights to accelerate the pace of innovation, today reported results for the third quarter ended September 30, 2021.
Third Quarter 2021 Financial Highlights
- Revenues of $442.1 million and Adjusted Revenues(1) of $442.2 million, increased 55% and 54%, respectively, at constant currency
- Organic revenues(1), which exclude the impact of acquisitions and divestitures, increased 3%, at constant currency
- Net income of $0.9 million improved 100%; Net income per diluted share of $0.00 improved $0.47
- Adjusted Net Income(1) of $113.6 million increased 94%; Adjusted Income per diluted share(1) (EPS) of $0.16 increased 14% or $0.02. Adjusted EPS impacted by 72% increase in weighted average ordinary shares outstanding primarily driven by the acquisition of CPA Global and the June 2021 ordinary share and mandatory convertible preferred share offering to finance a portion of the purchase price for the pending acquisition of ProQuest
- Adjusted EBITDA(1) of $190.0 million increased 76% and Adjusted EBITDA Margin(1) of 43% increased 520 basis points
Nine Months Ended September 30, 2021 Financial Highlights
- Revenues of $1,316.2 million and Adjusted Revenues(1) of $1,320.7 million increased 62% and 61%, respectively, at constant currency
- Organic revenues([1]), which exclude the impact of acquisitions and divestitures, increased 5%, at constant currency
- Net loss of $105.3 million improved 69%; Net loss per diluted share of $(0.17) improved $0.74
- Adjusted Net Income(1) of $312.0 million increased 103%; Adjusted Income per diluted share(1) (EPS) of $0.48 increased 23% or $0.09
- Adjusted EBITDA(1) of $543.8 million increased 90% and Adjusted EBITDA Margin(1) of 41% increased 560 basis points
- Cash Flow from Operations increased $177.5 million to $305.5 million; Adjusted Free Cash Flow(1) increased $187.1 million to $315.6 million
“Clarivate delivered improved year over year results in the third quarter and we remain on track for a strong fourth quarter including organic revenue growth towards the upper-end of our 6% to 8% target with Adjusted EBITDA margins increasing to more than 50%,” said Jerre Stead, Executive Chairman and CEO. “We continue to work with regulators on our pending acquisition of ProQuest and remain hopeful that we can close the transaction by the end of 2021.”
The Company also announced that its Board of Directors approved the extension of its $250 million ordinary share repurchase program through January 31, 2022. The program was set to expire on October 31, 2021.
Selected Financial Information
The results for the three and nine months ended September 30, 2021 include contributions from the following acquisitions: 1) CPA Global, which was completed in October 2020; 2) Beijing Incopat Co., Ltd (“IncoPat”), which was completed in October 2020; 3) Hanlim IPS Co., Ltd (“Hanlim”), which was completed in November 2020; and 4) Bioinfogate, which was completed in August 2021, for which there were no comparable amounts in the three and nine months ended September 30, 2020. The results for the three and nine months ended September 30, 2021 exclude the results of Techstreet, which was divested in November 2020.
| Three Months Ended September 30, | Change | Nine Months Ended September 30, | Change | ||||||||||||||||||||||||||
| (in millions, except percentages and per share data) | 2021 | 2020 | $ | % | 2021 | 2020 | $ | % | |||||||||||||||||||||
| Revenues, net | $ | 442.1 | $ | 284.4 | $ | 157.8 | 55.5 | % | $ | 1,316.2 | $ | 798.5 | $ | 517.7 | 64.8 | % | |||||||||||||
| Adjusted revenues, net(1) | $ | 442.2 | $ | 286.5 | $ | 155.7 | 54.4 | % | $ | 1,320.7 | $ | 805.9 | $ | 514.8 | 63.9 | % | |||||||||||||
| Annualized Contract Value (ACV) | $ | 936.7 | $860.9 | $ | 75.8 | 8.8 | % | $ | 936.7 | $860.9 | $ | 75.8 | 8.8 | % | |||||||||||||||
| Net income (loss) | $ | 0.9 | $ | (182.0) | $ | 182.9 | 100.5 | % | $ | (105.3) | $ | (336.9) | $ | 231.6 | 68.7 | % | |||||||||||||
| Net income (loss) per share | $ | 0.00 | $ | (0.47) | $ | 0.47 | 100.0 | % | $ | (0.17) | $ | (0.91) | $ | 0.74 | 81.3 | % | |||||||||||||
| Weighted-average shares outstanding (diluted) | 645.9 | 387.8 | — | 66.6 | % | 622.5 | 369.0 | — | 68.7 | % | |||||||||||||||||||
| Adjusted EBITDA(1) | $ | 190.0 | $ | 108.2 | $ | 81.8 | 75.6 | % | $ | 543.8 | $ | 286.6 | $ | 257.2 | 89.7 | % | |||||||||||||
| Adjusted net income (loss)(1) | $ | 113.6 | $ | 58.5 | $ | 55.1 | 94.2 | % | $ | 312.0 | $ | 153.5 | $ | 158.5 | 103.3 | % | |||||||||||||
| Adjusted diluted EPS(1) | $ | 0.16 | $ | 0.14 | $ | 0.02 | 14.3 | % | $ | 0.48 | $ | 0.39 | $ | 0.09 | 23.1 | % | |||||||||||||
| Weighted average ordinary shares (diluted)(2) | 699.8 | 407.6 | — | 71.7 | % | 647.5 | 390.5 | — | 65.8 | % | |||||||||||||||||||
| Net cash provided by operating activities | $ | 43.8 | $ | 20.5 | $ | 23.3 | 113.7 | % | $ | 305.5 | $ | 128.0 | $ | 177.5 | 138.7 | % | |||||||||||||
| Free cash flow(1) | $ | 19.7 | $ | (5.5) | $ | 25.2 | 458.2 | % | $ | 219.3 | $ | 49.4 | $ | 169.9 | 343.9 | % | |||||||||||||
| Adjusted free cash flow(1) | $ | 57.1 | $ | 8.9 | $ | 48.2 | 541.6 | % | $ | 315.6 | $ | 128.5 | $ | 187.1 | 145.6 | % | |||||||||||||
(Amounts in tables may not sum due to rounding)
- Non-GAAP measure. Please see “Reconciliation to Certain Non-GAAP measures” in this earnings release for important disclosures and reconciliations of these financial measures to the most directly comparable GAAP measure. These terms are defined elsewhere in this earnings press release.
- Calculated assuming a net income position compared to a net loss position on the statement of operations for calculating Adjusted net income and Adjusted diluted EPS.
Revenues, net, for the third quarter of 2021 increased $157.8 million, or 55.5%, to $442.1 million, compared to the prior-year period. On a constant currency basis, revenues, net, increased 54.6% for the third quarter of 2021. Adjusted revenues, net, which excludes the impact of deferred revenues resulting from purchase accounting adjustments primarily related to acquisitions, increased $155.7 million or 54.4%, to $442.2 million, compared to the third quarter of 2020. On a constant currency basis, Adjusted revenues, net, increased 53.5% for the third quarter of 2021.
Organic revenues(1), which exclude the impact of acquisitions and divestitures, increased 3.1% on a constant currency basis for the third quarter of 2021 compared to the prior year period, due to higher subscription and transactional revenues. For the nine months ended September 30, 2021, organic revenues, net, increased 4.8% at constant currency, compared to the prior year period.
Subscription revenues for the third quarter of 2021 increased $24.4 million, or 11.0%, to $246.5 million, compared to the prior-year period, primarily driven by the acquisition of CPA Global, partially offset by the Techstreet divestiture. On a constant currency basis, subscription revenues increased 10.0% for the third quarter of 2021. Organic subscription revenues(1) increased 3.2% on a constant currency basis for the third quarter of 2021 compared to the prior year period, due to higher life sciences, healthcare data solutions, and CompuMark revenues. For the nine months ended September 30, 2021, organic subscription revenues increased 3.5% at constant currency, compared to the prior year period.
Re-occurring revenues for the third quarter of 2021 were $110.4 million (no prior year comparable amount), primarily from the patent renewals business acquired in the CPA Global acquisition.
Transactional revenues for the third quarter of 2021 increased $21.0 million, or 32.5%, to $85.4 million, compared to the prior-year period. On a constant currency basis, transactional revenues increased 32.1% for the third quarter of 2021, primarily due to the acquisition of CPA Global, partially offset by the Techstreet divestiture. Organic transactional revenues(1) increased 2.7% on a constant currency basis, compared to the third quarter of 2020, due to higher trademark search volumes, stronger back file and custom data sales. For the nine months ended September 30, 2021, organic transactional revenues increased 9.4% at constant currency, compared to the prior year period.
Net income for the third quarter of 2021 was $0.9 million, or $0.00 per share, compared to Net loss of $(182.0) million, or $(0.47) per share, in the prior-year period, primarily driven by improved income from operations and mark to market adjustments on financial instruments, partially offset by higher interest expense.
Adjusted EBITDA for the third quarter 2021 was $190.0 million, an increase of $81.8 million or 75.6%, compared to the prior-year period, driven by the earnings contribution from acquisitions, organic growth and cost savings from integration programs.
Adjusted net income for the third quarter of 2021 was $113.6 million, an increase of $55.1 million or 94.2%, compared to the prior year period, driven by higher revenues and ongoing cost savings initiatives.
Adjusted diluted earnings per share was $0.16 for the third quarter of 2021, compared to $0.14 in the prior-year period, as strong growth in Adjusted net income was offset by a 71.7% increase in weighted average ordinary shares outstanding primarily driven by the acquisition of CPA Global and the June 2021 ordinary share and mandatory convertible preferred share offering to finance a portion of the purchase price for the pending acquisition of ProQuest.
Balance Sheet and Cash Flow
At September 30, 2021, cash and cash equivalents of $2.5 billion increased $2.2 billion, compared to December 31, 2020, primarily driven by the June 2021 equity offering of $1.4 billion in net proceeds of 5.25% Series A mandatory convertible preferred shares and $728.1 million in net proceeds of ordinary shares after deducting underwriting discounts and estimated offering expenses payable. Restricted cash was $1.9 billion at September 30, 2021, which primarily represents the proceeds from the debt offering in June 2021 and the subsequent exchange offering in August 2021, which is being held in escrow until the completion of the pending acquisition of ProQuest. The Company intends to use the proceeds to finance a portion of the purchase price for its pending acquisition of ProQuest.
The Company’s total debt outstanding at September 30, 2021 was $5.4 billion, an increase of $1.8 billion compared to December 31, 2020, primarily due to the June 2021 debt offering of 3.875% senior secured notes due 2028 and 4.875% senior notes due 2029 and the subsequent exchange offering in August 2021. The Company intends to use the proceeds to finance a portion of the purchase price for its pending acquisition of ProQuest.
Net cash provided by operating activities was $305.5 million for the nine months ended September 30, 2021, compared to net cash provided by operating activities of $128.0 million for the prior year period. Adjusted free cash flow for the nine months ended September 30, 2021, was $315.6 million, an increase of $187.1 million, compared to the prior year period, as a result of growth in revenues and Adjusted EBITDA.
Reaffirmed Outlook for 2021 (forward-looking statement)
The full year outlook presented below assumes no further currency movements, acquisitions, divestitures, or unanticipated events. Additionally, the outlook excludes any contribution from the pending acquisition of ProQuest.
The below outlook includes Non-GAAP measures. Please see “Reconciliation to Certain Non-GAAP measures” presented below for important disclosure and reconciliations of these financial measures to the most directly comparable GAAP measure. These terms are defined elsewhere in this earnings press release.
| Outlook | |
| Adjusted Revenues | $1.80B to $1.84B |
| Adjusted EBITDA | $795M to $825M |
| Adjusted EBITDA margin | 44% to 45% |
| Adjusted Diluted EPS(1) | $0.70 to $0.74 |
| Adjusted Free Cash Flow | $450M to $500M |
- Adjusted Diluted EPS for 2021 is calculated based on approximately 668.4 million fully diluted weighted average shares outstanding.
Conference Call and Webcast
Clarivate will host a conference call and webcast today to review the results for the third quarter at 8:00 a.m. Eastern Time. The conference call will be simultaneously webcast on the Investor Relations section of the company’s website.
Interested parties may access the live audio broadcast by dialing 1-888-317-6003 in the United States, 1-412-317-6061 for international, and 1-866-284-3684 in Canada. The conference ID number is 3877359. An audio replay will be available approximately two hours after the completion of the call at 1-877-344-7529 in the United States, 1-412-317-0088 for international, and 1-855-669-9658 in Canada. The Replay Conference ID number is 10153163. The recording will be available for replay through November 11, 2021. The webcast can be accessed at https://services.choruscall.com/links/clvt211028.html and will be available for replay.
Investor Day Conference on November 9, 2021
Clarivate will host a Virtual Investor Day Conference on Tuesday, November 9, 2021. Management will provide an update on the business, with presentations starting at 10:00 AM Eastern Time and concluding at approximately 1:00 PM Eastern Time.
All are invited to listen to the event and view the presentation via webcast on the Clarivate Investor Relations website at http://ir.clarivate.com/. To join the webcast please visit https://clarivateir.virtualevent.page/stream-public/. A replay will also be available as a webcast on the investor relations section of the Company’s website.
Use of Non-GAAP Financial Measures
Non-GAAP results are not presentations made in accordance with U.S. generally accepted accounting principles (“GAAP”) and are presented only as a supplement to our financial statements based on GAAP. Non-GAAP financial information is provided to enhance the reader’s understanding of our financial performance, but none of these non-GAAP financial measures are recognized terms under GAAP. They are not measures of financial condition or liquidity, and should not be considered as an alternative to profit or loss for the period determined in accordance with GAAP or operating cash flows determined in accordance with GAAP. As a result, you should not consider such measures in isolation from, or as a substitute for, financial measures or results of operations calculated or determined in accordance with GAAP.
We use non-GAAP measures in our operational and financial decision-making. We believe that such measures allow us to focus on what we deem to be a more reliable indicator of ongoing operating performance and our ability to generate cash flow from operations and we also believe that investors may find these non-GAAP financial measures useful for the same reasons. Non-GAAP measures are frequently used by securities analysts, investors, and other interested parties in their evaluation of companies comparable to us, many of which present non-GAAP measures when reporting their results. These measures can be useful in evaluating our performance against our peer companies because we believe the measures provide users with valuable insight into key components of GAAP financial disclosures. However, non-GAAP measures have limitations as analytical tools and because not all companies use identical calculations, our presentation of non-GAAP financial measures may not be comparable to other similarly titled measures of other companies.
Definitions and reconciliations of non-GAAP measures, such as Adjusted Revenues, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, Adjusted Free Cash Flow, Standalone Adjusted EBITDA, and organic revenue to the most directly comparable GAAP measures are provided within the schedules attached to this release. Our presentation of non-GAAP measures should not be construed as an inference that our future results will be unaffected by any of the adjusted items, or that any projections and estimates will be realized in their entirety or at all.
Forward-Looking Statements
This communication contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management’s current views concerning future business, events, trends, contingencies, financial performance, or financial condition, appear at various places in this communication and may use words like “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “likely,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “see,” “seek,” “should,” “strategy,” “strive,” “target,” “will,” and “would” and similar expressions, and variations or negatives of these words. Examples of forward-looking statements include, among others, statements we make regarding: guidance outlook and predictions relating to expected operating results, such as revenue growth and earnings; our expectations around our ability to consummate our pending acquisition of ProQuest, which is subject to customary closing conditions including receipt of approval under the Hart-Scott-Rodino Antitrust Improvements Act of 1976; strategic actions such as acquisitions, joint ventures, and dispositions, including the anticipated benefits therefrom, and our success in integrating acquired businesses; anticipated levels of capital expenditures in future periods; our ability to successfully realize cost savings initiatives and transition services expenses; our belief that we have sufficiently liquidity to fund our ongoing business operations; expectations of the effect on our financial condition of claims, litigation, environmental costs, the COVID-19 pandemic and governmental responses thereto, contingent liabilities, and governmental and regulatory investigations and proceedings; and our strategy for customer retention, growth, product development, market position, financial results, and reserves. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management’s current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are difficult to predict and many of which are outside of our control. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include those factors discussed under the caption “Risk Factors” in our 2020 annual report on Form 10-K/A, along with our other filings with the U.S. Securities and Exchange Commission (“SEC”). However, those factors should not be considered to be a complete statement of all potential risks and uncertainties. Additional risks and uncertainties not known to us or that we currently deem immaterial may also impair our business operations. Forward-looking statements are based only on information currently available to our management and speak only as of the date of this communication. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Please consult our public filings with the SEC or on our website at www.clarivate.com.
About Clarivate
Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world’s most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.
Media Contact:
Tabita Seagrave, Head of Global Corporate Communications
tabita.seagrave@clarivate.com
Investor Relations Contact:
Mark Donohue, Head of Global Investor Relations
mark.donohue@clarivate.com
215-243-2202
[1] Represents a Non-GAAP measure. Please see “Reconciliation to Certain Non-GAAP measures” in this earnings release for important disclosures and reconciliations of these financial measures to the most directly comparable GAAP measure. These terms are defined elsewhere in this earnings press release.
